The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the development of a mini-bioreactor designed to enhance organoid culture outcomes.

This technology includes a mini-bioreactor designed to improve organoid outcomes in cell culture applications. The bioreactor system is a multi-well, 3D-printed device that fits standard 100 mm cell culture dishes and utilizes a central stirring mechanism to create a controlled laminar flow. This innovative design addresses the common challenges in organoid culture, such as non-specific adherence and fusion, while enhancing mass transfer without the shear stress typically associated with other bioreactor systems.

The technical solution provided by this bioreactor is significant because it simplifies the organoid culture process by integrating a single-component system that is compatible with standard lab equipment. This means that researchers can easily adopt this technology without needing specialized training or additional components. The ability to track individual organoids longitudinally further enhances its utility in research settings, making it an attractive option for laboratories focused on organoid studies.

The licensing opportunity for this technology is promising, as it can be developed and produced in less than two years. Companies that manufacture cell culture vessels, such as Corning, Thermo Fisher, and VWR, may find this bioreactor particularly appealing for their product lines. Collaboration with the inventors is encouraged to explore the full commercial potential of this innovative bioreactor system.